Understanding Liver Cysts: Are They Dangerous?
Explore liver cysts, their causes, symptoms, risks, treatment, and prevention strategies to demystify this common condition.
Maintaining Hunger Sensation to Delay Aging
Research indicates that the sensation of hunger triggered by calorie restriction can influence gene expression, helping to delay aging and extend lifespan by up to 35%.
Posted inAI Clinical Updates Gastroenterology news Specialties
Explainable Artificial Intelligence for Predicting Refractory Ulcerative Colitis: Insights from a Japanese Nationwide Registry
A machine learning model using nationwide registry data accurately predicts long-term remission in refractory ulcerative colitis and identifies key prognostic factors such as pseudopolyps.
Consecutive Fecal Microbiota Transplantation in MASLD: Insights from a Double-Blind Randomized Controlled Trial
A double-blind RCT found that three consecutive fecal microbiota transplantations did not significantly improve hepatic steatosis or metabolic parameters in patients with MASLD, suggesting patient selection based on microbiota diversity may be crucial.
Posted inClinical Updates Gastroenterology news Specialties
Low-Dose Hydrocortisone in Cirrhotic Patients With Septic Shock: A Double-Blind Randomised Placebo-Controlled Trial
This trial evaluated low-dose hydrocortisone in cirrhotic patients with septic shock, finding no improvement in 28-day mortality or shock resolution compared to placebo.
Waist Size Proves Key to Assessing Liver Health
Waist circumference is a superior predictor of metabolic liver diseases, outperforming BMI and other body metrics in assessing MASLD, MASH, and liver stiffness risks.
Perinatal Antibiotic Exposure Alters Neonatal Gut Microbiota in Preterm Infants: Clinical Implications for Infection Risk and Microbial Maturation
Perinatal antibiotic exposure in preterm infants disrupts gut microbiota composition, increasing pathogenic bacteria and reducing beneficial species, with implications for infection risk and the protective role of breastfeeding.
Probiotics and Prebiotics: Unlocking the Secrets of Gut Health and Immunity
Explore how probiotics and prebiotics fortify gut health, boosting immune response and overall well-being.
Posted inGastroenterology news Psychiatry
Your Gut, Your Mood: How the ‘Second Brain’ Can Beat the Blues
Explore how the gut, often called the 'second brain,' influences mood and mental health, and learn ways to nurture this connection for better emotional well-being.
Posted inGastroenterology news Specialties
Two Types of Intestinal Polyps with High Risk of Developing into Colorectal Cancer: Four Signs During Bowel Movements Indicating Polyps
Intestinal polyps are mucosal growths that can lead to colorectal cancer. Two types, adenomatous and familial adenomatous polyps, carry a high cancer risk. Early removal and lifestyle adjustments are key to prevention.
Posted inGastroenterology news Specialties
Recognizing Abnormal Bowel Movements: Could Intestinal Polyps Be the Cause?
Intestinal polyps are often benign but can become cancerous. This article explores symptoms, risk factors, and colonoscopy guidelines to help identify and prevent colorectal cancer.
Posted inClinical Updates Gastroenterology Specialties
Guselkumab for Crohn’s Disease and Ulcerative Colitis: Efficacy and Safety from Recent Phase 3 Trials
Phase 3 studies demonstrate guselkumab's efficacy and safety as induction and maintenance therapy for moderate-to-severe Crohn's disease and ulcerative colitis, with superiority over placebo and favorable safety profiles.
Distinct Genomic Mutation Patterns in Early-Onset Colorectal Cancer: Implications for Clinical Stratification and Precision Medicine
A large international study reveals unique somatic mutation profiles and higher mutational burden in hypermutated early-onset colorectal cancer, highlighting the need for age-specific molecular diagnostics and management strategies.
Posted inClinical Updates Gastroenterology news Specialties
Pre-emptive TIPS vs Glue Obliteration for Acute Fundal Variceal Bleeding in Cirrhosis: Key Insights from the GAVAPROSEC Trial
The GAVAPROSEC trial demonstrates that pre-emptive TIPS significantly reduces 1-year mortality and rebleeding in cirrhotic patients with acute fundal gastric variceal bleeding compared to glue obliteration plus NSBB.
Posted inClinical Updates Gastroenterology news Specialties
EASE-CD: A Validated Endoscopic Ulcer Activity Score for Crohn’s Disease—Clinical Utility and Evidence from Randomized Trials
The EASE-CD index offers a reliable, validated, and responsive tool for quantifying Crohn's disease ulcer activity in clinical trials and practice, improving upon prior endoscopic indices.
Efimosfermin Alfa (BOS-580) in Metabolic Dysfunction-Associated Steatohepatitis: Promising Phase 2a Results
Efimosfermin alfa, a long-acting FGF21 analogue, demonstrated a favorable safety profile and significant reductions in hepatic fat in patients with metabolic dysfunction-associated steatohepatitis (MASH) in a phase 2a randomized controlled trial.
Posted inClinical Updates Gastroenterology news Specialties
Targeting TL1A in IBD: Safety and Efficacy of Tulisokibart in Crohn’s Disease and Ulcerative Colitis—Emerging Phase 2 Data
Phase 2 trials show anti-TL1A antibody tulisokibart offers potential efficacy and good tolerability in refractory Crohn’s disease and ulcerative colitis, with ongoing phase 3 studies to confirm findings.
Interval Colorectal Cancer Risk and Outcomes after Positive FIT with Follow-Up Colonoscopy in Taiwan Screening Program
A Taiwanese cohort study reveals higher interval colorectal cancer incidence and mortality after follow-up colonoscopy for positive FIT compared to negative FIT, highlighting risk stratification and adenoma detection rate impact on outcomes.
Efruxifermin for Compensated Liver Cirrhosis in MASH: Phase 2b Results and Clinical Implications
A phase 2b trial found that efruxifermin did not significantly improve fibrosis at 36 weeks in patients with compensated cirrhosis due to MASH, though longer-term benefit was suggested at 96 weeks.
Posted inClinical Updates Gastroenterology news Specialties
Multidose Ondansetron After Emergency Visits: Reducing Gastroenteritis Severity in Children
A randomized trial shows that multidose ondansetron after pediatric ED visits for gastroenteritis reduces moderate-to-severe illness, though impact on vomiting duration and healthcare utilization is limited.